Fundai

Shahid Ghazi Pharmaceutical Company (DGHAZI) income statement

Operating revenue through to net profit and earnings per share

Ticker
DGHAZI
Industry
Pharmaceuticals
Market
Iran Fara Bourse

Latest periods

Latest 6-month periods, in million rials
ItemTo 1405/06/31To 1404/06/31To 1403/06/31To 1402/06/31To 1401/06/31To 1400/06/31
Operating revenue55,435,62415,358,8628,701,7107,416,8255,422,0181,434,823
Cost of operating revenue-14,938,342-6,493,744-4,067,730-3,219,088-2,620,770-519,154
Gross profit (loss)40,497,2828,865,1184,633,9804,197,7372,801,248915,669
Selling, general and administrative expenses-1,349,913-588,960-396,081-295,417-208,816-84,695
Other income441,838164,498118,40893,51281,71144,852
Other expenses-52,590-20,952-20,653-11,207-13,389-11,240
Operating profit (loss)39,536,6178,419,7044,335,6543,984,6252,660,754864,586
Finance costs-2,135,150-1,089,232-414,294-281,614-239,261-101,356
Other non-operating income and expenses171,12712,404-28,750-7,4147,15423,675
Profit (loss) from continuing operations before tax37,572,5947,342,8763,892,6103,695,5972,428,647786,905
Current year tax-9,529,772-1,483,003-883,111-686,749-609,310-196,400
Net profit (loss) from continuing operations28,042,8225,859,8733,009,4993,008,8481,819,337590,505
Net profit (loss)28,042,8225,859,8733,009,4993,008,8481,819,337590,505
Basic earnings (loss) per share2,705 rials594 rials1,775 rials1,774 rials2,145 rials702 rials
Net earnings (loss) per share, rials2,700 rials593 rials1,771 rials1,770 rials2,141 rials695 rials
Capital10,390,0009,890,0001,700,0001,700,000850,000850,000

Reporting periods

56 periods are on file for this report, from the period ending 1393/06/31 to the period ending 1405/06/31.